Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy Apolo, Andrea B. , Ostrovnaya, Irina , Halabi, Susan ... - - J. Natl. Cancer Inst - 2013 Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90102
Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) Dressler, Lynn G. , Deal, Allison M. , Owzar, Kouros ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcome - CALGB-40101 , CALGB-50303 , CALGB-80101 , CALGB-80203 , CALGB-80303 , CALGB-80405 , CALGB-90401
Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies Goetz, Matthew P. , Sun, James X. , Suman, Vera J. , Silva, Grace O. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original - Primary - PPP - NCCTG-89-30-52
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147 Gonsalves, Wilson I. , Mahoney, Michelle R. , Sargent, Daniel J. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary - Primary - Correl Sci NOS - N0147
Generalizability of Trial Results to Elderly Medicare Patients with Advanced Solid Tumors (Alliance 70802) Lamont, Elizabeth B. , Schilsky, Richard L. , He, Yulei , Muss, Hyman ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary - Primary - Older Adult - CALGB-70802
DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon Cancer Treatment (NCCTG N0147) Lee, Adam M. , Shi, Qian , Pavey, Emily , Alberts, Steven R. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - NCCTG-N0147
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance) Ligibel, Jennifer A. , Cirrincione, Constance T. , Liu, Minetta ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary - Primary - Breast - C9741 , CALGB-40902
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer Ng, Kimmie , Meyerhardt, Jeffrey A. , Chan, Andrew T. , Sato, Kaori ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original - Long-Term-Followup - Prevention - C89803
Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial Ogino, Shuji , Liao, Xiaoyun , Imamura, Yu , Yamauchi, Mai ... - - J. Natl. Cancer Inst - 2013 Manuscript - Secondary - Primary - GI - CALGB-89803
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial Perez, Edith A. , Ballman, Karla V. , Mashadi-Hossein, Afshin ... - - J. Natl. Cancer Inst - 2016 Manuscript - Secondary - Primary - Breast - N9831
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer Taieb, Julien , Le Malicot, Karine , Shi, Qian ... - - J. Natl. Cancer Inst - 2016 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - N0147
25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance) Van Loon, Katherine , Owzar, Kouros , Jiang, Chen , Kindler, Hedy L. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary - Primary - GI - CALGB-151006 , CALGB-80303
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients Yoon, Harry H. , Shi, Qian , Alberts, Steven R. ... - - J. Natl. Cancer Inst - 2015 Manuscript - Secondary-not-in-original - Primary - GI - N0147
